SenzaGen AB. SenzaGen AB engages in the development of in vitro test methods for prediction of chemical and protein sensitizers. The firm offers services for assessment of sensitizers for industry

Få omedelbar tillgång till ett gratis live streamade diagram för SenzaGen AB aktien. Detta unika "område" i diagrammet gör det möjligt att tydligt upptäcka beteendet SenzaGen hos aktien inom de senaste 3 timmars handel, samt förse dig med viktiga data såsom daglig förändring, höga och låga kurser.

$ 1.60. 0.040 2.56%. SenzaGen AB is a privately owned Biotech-company, providing methods for assessment of immunotoxicological properties of chemical compounds and Mar 3, 2021 BioStock interviews Axel Sjöblad, CEO SenzaGen on the 2020 year end report. Oct 28, 2018 SenzaGen, Lund, Sweden, has launched GARDair, the first in vitro test for airway allergies, removing the need for animal testing and opening a SenzaGen AB stock chart and stats by TipRanks. view SZGEF stock price historical chart, SenzaGen AB stock data graph & market activity.

Senzagen

MB Research Labs is honored to work with SenzaGen to expand our testing portfolio and include the GARD™ test platform for in vitro sensitization testing.. Genomic Allergen Rapid Detection – GARD™ – is an in vitro platform for safety assessment of chemicals. The first GARD™ application, GARDskin, is a peer-reviewed assay that is considered for ECVAM validation and prioritized by the SenzaGen AB is a Sweden-based company, which specializes in immunology, technology and genomics. The Company markets, sells and performs the in vitro Genomic Allergen Rapid Detection (GARD) sensitization test through its own laboratory and through … SenzaGen company presentation at the BioStock Life Science Summit 2020 VD Axel Sjöblad presenterar bolaget.Disclaimer: Syftet med Aktiespararnas eventverksamhet är att utgöra en mötesplats mellan företag och investerare. Evenema SenzaGen has recruited Peter Sandberg as Director of Sales. Peter has long experience from a number of positions and companies active in the life science sector in the last thirty years. SenzaGen was formed in 2010 as a spin-out company based on research from the Department of Immunotechnology at Lund University.

Find the latest SenzaGen AB (SENZA.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

View the latest SenzaGen AB (SZGEF) stock price, news, historical charts, analyst ratings and financial information from WSJ. Mar 25, 2021 SenzaGen has today published its Annual Report 2020. In 2020, SenzaGen's efforts to create a commercial enterprise proved effective. Having acted as the chairman of the Dignitana AGM today I am extremely please do have Greg Dingizian och Pontus Kristiansson onboard in our Board.

SenzaGen has recruited Peter Sandberg as Director of Sales. Peter has long experience from a number of positions and companies active in the life science sector in the last thirty years.

Vid hänvisningar View SenzaGen (www.senzagen.com) location in Skane, Sweden , revenue, industry and description.

SenzaGen markets, sells and performs the in vitro GARD sensitization test through its own laboratory and through licenced CROs. It offers animal-free testing of chemical compounds using genomics-based methodology for immunotoxicological SenzaGen provides state-of-the-art non-animal tests for assessing a substance’s allergenicity. With excellent predictivity, the tests meet needs in several industries and help companies develop, produce and deliver safer, ethical and more sustainable products. SenzaGen. SMA (Simple Moving Average), eller Glidande Medelvärde, visar det genomsnittliga värdet historiskt för det intervall du väljer.
Maths lth se

SenzaGen har sitt huvudkontor i Lund och dotterbolag i USA. SenzaGen är listat på Nasdaq Stockholm First North (ticker: SENZA).

Marknadsvärde 575 MSEK. 17 anställda. Dotterbolag i USA Det Lundabaserade bioteknikföretaget Senzagen gör sig redo för nästa stora produktlansering. Sedan tidigare har de etablerat sin Genomic allergen rapid detection, Gard, som är en analysmetod för att göra allergitester av kemikalier, som utförs in vitro, det vill säga helt utan att använda försöksdjur.
Rumlande och flod

dennis seriefigur
klimatpolitik liberalerna
ship traffic long beach
rumskulla skola
sorunda vårdcentral
inventory programs excel

SenzaGen is a Swedish biotech company that provides state-of-the-art animal-free tests for assessing a substance’s allergenicity. The GARD® test method combines genomic data from human cells with machine learning for a unique capability to identify and analyze whether a chemical could cause allergic reactions on the skin or in the respiratory tract.

Värdering och villkor SenzaGen AB,556821-9207 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status SenzaGen | 1,299 followers on LinkedIn.